EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitHistorischer BeitragOpen Access · CC BY 4.0

The History of Nerve Growth Factor: From Molecule to Drug

Elizabeth Gavioli, Flavio Mantelli, Maria Candida Cesta iD, Marta Sacchetti, Marcello Allegretti iD

Biomolecules · 2024

DOI: 10.3390/biom14060635 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2024. Verfasst von Elizabeth Gavioli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dompé U.S. Inc., 181 2nd Avenue, STE 600, San Mateo, CA 94401, USA. Hauptthemen laut MEDLINE: Nerve Growth Factor. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nerve growth factor (NGF), the first neurotrophin to be discovered, has a long and eventful research journey with a series of turning points, setbacks, and achievements. Since the groundbreaking investigations led by Nobel Prize winner Rita Levi-Montalcini, advancements in the comprehension of NGF’s functions have revolutionized the field of neuroscience, offering new insights and opportunities for therapeutic innovation. However, the clinical application of NGF has historically been hindered by challenges in determining appropriate dosing, administration strategies, and complications related to the production process. Recent advances in the production and scientific knowledge of recombinant NGF have enabled its clinical development, and in 2018, the United States Food and Drug Administration approved cenegermin-bkbj, a recombinant human NGF, for the treatment of all stages of neurotrophic keratitis. This review traces the evolutionary path that transformed NGF from a biological molecule into a novel therapy with potential research applications beyond the eye. Special emphasis is put on the studies that advanced NGF from discovery to the first medicinal product approved to treat a human disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nerve Growth FactorHumansAnimalsRecombinant ProteinsHistory, 20th CenturyHistory, 21st Century

Stichwörter der Autor:innen

biomoleculecenegermindrug discoverynerve growth factorneurotrophic keratitisneurotrophins

Substanzen

Nerve Growth FactorRecombinant Proteins

Autor:innen und Institutionen

  • Dompé U.S. Inc., 181 2nd Avenue, STE 600, San Mateo, CA 94401, USA.
  • Dompé farmaceutici S.p.A., Via Santa Lucia, 6, 20122 Milano, Italy.

ORCID-Profile: Maria Candida Cesta, Marcello Allegretti

Zitieren

APA

Gavioli, E., Mantelli, F., Cesta, M. C., Sacchetti, M., & Allegretti, M. (2024). The History of Nerve Growth Factor: From Molecule to Drug. Biomolecules. https://doi.org/10.3390/biom14060635

Vancouver

Gavioli E, Mantelli F, Cesta MC, Sacchetti M, Allegretti M. The History of Nerve Growth Factor: From Molecule to Drug. Biomolecules. 2024. doi:10.3390/biom14060635

BibTeX
@article{Gavioli2024,
  author = {Gavioli, Elizabeth and Mantelli, Flavio and Cesta, Maria Candida and Sacchetti, Marta and Allegretti, Marcello},
  title = {The History of Nerve Growth Factor: From Molecule to Drug},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14060635}
}
Kostenlos starten →